Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HCV core lipid binding domain monoclonal antibodies

HCV core lipid binding domain monoclonal antibodies

US Patent 9371374 · Granted Jun 21, 2016

Estimated economic value: $133,288,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Assays for detecting SARS-CoV-22024
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2022
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2022
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2022
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2022
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2022
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2022
Detection methods employing HCV core lipid and DNA binding domain monoclonal ant2022
Anti-GP73 monoclonal antibodies and methods of obtaining the same2022
Anti-GP73 monoclonal antibodies and methods of obtaining the same2022
Anti-GP73 monoclonal antibodies and methods of obtaining the same2022
Subject anti-HCV antibody detection assays employing NS3 capture peptides2022